![Atmo Biosciences CEO Mal Hebblewhite with the ingestible gas-sensing capsule](https://planetinnovation.com/wp-content/uploads/2021/09/Mal_Hebblewhite_capsule_website-scaled-e1632361482637.jpg)
Atmo Biosciences secures $9.6 million in oversubscribed capital raise
Atmo Biosciences, a digital health company that is developing the world’s first ingestible gas-sensing capsule for monitoring gut health, has closed an oversubscribed A$9.6m capital raise.